WebShares of Inovio Pharmaceuticals (NASDAQ: INO) were down more than 10% on Tuesday afternoon, falling to a 52-week low of $0.07036 a share at one point. The biotechnology … WebInovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript. Aug 9, 2024.
Did you know?
WebMar 1, 2024 · Inovio, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.13 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by... WebInovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human …
WebMar 15, 2024 · Inovio Pharmaceuticals, Inc. (INOVIO) is a biotechnology company. The Company is focused on bringing to market designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus (HPV). WebApr 11, 2024 · Inovio Pharmaceuticals, Inc. News. Summary INO US45773H2013. INOVIO PHARMACEUTICALS, INC. (INO) Add to my list. Report. Delayed Nasdaq - 04:00:00 2024-04-11 pm EDT 0.7290: USD +0.10%: 08:01a: INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) at ECCMID …
WebApr 12, 2024 · INO Inovio Pharmaceuticals, Inc. Stock Price & Overview $0.77 0.07 ( +10.29%) 4:00 PM 04/06/23 NASDAQ $USD Post-Market: $0.76 -0.01 (-1.23%) 7:59 PM Summary Ratings Financials Earnings... Web1 day ago · Shares of Inovio Pharmaceuticals Inc. INO, -9.05% shed 9.05% to $0.85 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ ...
WebStock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebComplete Inovio Pharmaceuticals Inc. stock information by Barron's. View real-time INO stock price and news, along with industry-best analysis. simplification check reportWebInovio Pharmaceuticals Inc Follow Share $22.00 Mar 10, 3:13:15 PM GMT-6 · MXN · BMV · Disclaimer search Compare to In the news MarketWatch 1 day ago Inovio Pharmaceuticals Inc. stock... simplification by dear sirWebInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2024 Earnings Call Transcript March 1, 2024 Operator: Good afternoon, and welcome to the Inovio Pharmaceuticals Fourth Quarter … Find the latest Inovio Pharmaceuticals, Inc. (INO) stock discussion in Yahoo … Discover historical prices for INO stock on Yahoo Finance. View daily, weekly or … See Inovio Pharmaceuticals, Inc. (INO) Environment, Social and Governance … Find out the direct holders, institutional holders and mutual fund holders for … View the basic INO option chain and compare options of Inovio … See Inovio Pharmaceuticals, Inc. (INO) stock analyst estimates, including … Find out all the key statistics for Inovio Pharmaceuticals, Inc. (INO), including … Get the detailed quarterly/annual income statement for Inovio Pharmaceuticals, … Inovio Pharmaceuticals, Inc. 660 West Germantown Pike Suite 110 Plymouth … Inovio Pharmaceuticals, Inc. Technical Assessment: Bearish in the Intermediate … raymond james las vegas locationsWebNov 18, 2024 · Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases … simplification by rakesh yadavWebINO - Inovio Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to … simplification chapterWebInovio Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest INO financial statements, income statements and financial ratios. simplification calculator fractionsWebApr 12, 2024 · INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that an abstract has been accepted for presentation for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at … simplification calculator wolfram